The WIB-FAST Advisory Program launched in May with the following five women-led startups who are developing innovative and transformational therapeutic, diagnostic or device technologies to improve human health:

• Curiva
• MyoGene Bio
• NeurANO Bioscience
• SiVEC Biotechnologies
• TNC Medical

In the weeks leading up to the BIO International Convention, the founders will receive customized commercialization advising from a team of experts to assist them in different areas like positioning for capital (Angel, Seed or Series A), input on business strategy, and legal or scientific strategy.

Each company will present in the WIB-FAST track at Startup Stadium on June 14 at the BIO International Convention in San Diego—along with three FAST Alumni and WIB members–Nano PharmaSolutions, Navega Therapeutics and OncoXome. This is an exceptional opportunity to access key members of the investment community, venture philanthropy groups, strategic partners, and non-dilutive capital at the world’s largest biotechnology event.

The WIB-FAST program is open to early-stage female (co-)founders of pre-revenue life sciences companies who are developing highly innovative technologies that will have a meaningful impact on human health. WIB-FAST is designed to help women entrepreneurs who seek advising on raising capital (Angel, Seed or Series A), commercialization or business plans, and legal or scientific strategy.